GlassScriptPhysician profile
Casey Corbin Mccloud
NPI 1053722249
$2,627.14
in general payments reported to CMS, 2019-2025
30 companies · $415 in 2025
The $415 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $187 · 2021: $471 · 2022: $425 · 2023: $644 · 2024: $312 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.94 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $416.16 | 2020-2023 | |
| Astellas Pharma US INC | $287.05 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $211.28 | 2021-2025 | Slynd, Nuvessa |
| Medtronic, INC. | $175.98 | 2023-2025 | Venaseal, V-Loc 180 |
| Hologic Sales and Service, LLC | $155.83 | 2020-2025 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Mayne Pharma Commercial LLC | $134.80 | 2023-2024 | |
| Agile Therapeutics, INC. | $130.38 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $123.65 | 2019-2023 | |
| Exact Sciences Corporation | $116.33 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $85.38 | 2021-2024 | |
| Organon LLC | $81.27 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $77.82 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $72.51 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $67.35 | 2021-2022 | |
| Lupin INC. | $58.10 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $45.89 | 2019-2023 | Gardasil 9 |
| Aspira Women'S Health INC | $43.42 | 2022-2023 | Ova1 |
| Allergan, INC. | $41.61 | 2019-2020 | |
| Amgen INC. | $39.66 | 2020-2024 | Evenity, Prolia |
| Abiomed | $37.85 | 2024 | Impella |
| Avion Pharmaceuticals | $30.40 | 2021 | |
| Smith+Nephew, INC. | $28.59 | 2024 | Pico 7 |
| Sage Therapeutics, LLC | $27.83 | 2024 | |
| Therapeuticsmd, INC. | $27.23 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $27.02 | 2019-2021 | |
| Evofem Biosciences, INC. | $22.64 | 2024 | |
| Renovia INC | $17.51 | 2019 | |
| Millicent US INC | $16.12 | 2020 | |
| Shield Therapeutics INC | $15.63 | 2025 | |
| Scynexis, INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Mccloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.